For this series of Case Based Panel Discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie Brahmer to discuss treatment for...
Targeted Therapies - EGFR
Targeted Therapies - EGFR
If you have been NEWLY DIAGNOSED START HERE
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
2020 TTF EGFR SESSION - QA PANEL Preferred Chemo Regimen when Targeted Therapy Options are Exhausted
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
Cancer Type:
Disease Learning:
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
Cancer Type:
Disease Learning:
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 3
- View More
Articles
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
Cancer Journey:
Cancer Type:
Disease Learning:
Fast forward 1.5 years, and we now have the early results of LUX-Lung-7, and they show that these EGFR TKIs are not completely interchangeable...
Cancer Journey:
Cancer Type:
Disease Learning:
Community Forum
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is...
Cancer Journey:
Cancer Type:
MARCH 28, PUT IN ON YOUR CALENDARS. I always learn so much at the live patient forums even attending them virtually. Our faculty is outstanding in...
Cancer Journey:
Cancer Type:
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Cancer Type:
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
Cancer Type:
My wife was on Tarceva for over 6 1/2 years. Then she developed acquired resistance to Tarceva with prevascular and supraclevical lymph nodes...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 2
- View More